STOCK TITAN

Ascendis Pharma legal chief plans $4.44M share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Ascendis Pharma A/S Executive VP and Chief Legal Officer Michael Wolff Jensen reported plans to sell 18,349 ordinary shares, with an aggregate market value of $4,442,109 based on an indicative market price of $242.09 per share. The notice lists an approximate sale date of March 2, 2026.

The sales are described as non-discretionary transactions over multiple days under an established Rule 10b5-1 plan adopted September 7, 2023, in connection with vesting and settlement of equity awards. Jensen also reported selling 10,000 ordinary shares on December 4, 2025, for gross proceeds of $2,081,018.69.

Ordinary shares to be sold 18,349 shares Proposed sale
Aggregate market value $4,442,109 Shares to be sold
Indicative market price $242.09 per share Used for the proposed sale
Ordinary shares outstanding 61,977,408 shares As listed in the notice
Prior ordinary shares sold 10,000 shares December 4, 2025
Prior sale gross proceeds $2,081,018.69 December 4, 2025
Rule 10b5-1 plan adoption date September 7, 2023 Plan cited for the reported sales
10B51 plan regulatory
"performed under an established 10B51 plan"
restricted stock vesting financial
"RESTRICTED STOCK VESTING"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
gross proceeds financial
"Amount of Securities Sold | Gross Proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ASND shares is Michael Wolff Jensen planning to sell?

Michael Wolff Jensen reported plans to sell 18,349 ordinary shares, with an aggregate market value of $4,442,109 based on an indicative market price of $242.09 per share. The notice lists March 2, 2026, as the approximate sale date.

Why is Michael Wolff Jensen selling ASND shares?

The notice says the sales are for the vesting and settlement of equity awards. It describes them as non-discretionary transactions over multiple days under an established Rule 10b5-1 plan adopted September 7, 2023.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading